Status | Study |
Recruiting |
Study Name: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2013-01-02 Interventions: Drug: Fludarabine phosphate Gi |
Completed |
Study Name: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Date: 2012-12-11 Interventions: Biological: anti-endosialin/TEM1 monoclonal antibody MORAb-004 |
Active, not recruiting |
Study Name: Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Date: 2012-08-31 Interventions: Biological: indium In 111 anti-CD45 monoclonal antibody BC8 |
Withdrawn |
Study Name: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2012-07-20 Interventions: Drug: cyclophosphamide Given I |
Active, not recruiting |
Study Name: Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-04-26 Interventions: Biological: tetanus-CMV fusion peptide vaccine |
Active, not recruiting |
Study Name: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma Condition: Adult B Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Date: 2012-03-29 Interventions: Drug: Alisertib Given PO |
Terminated |
Study Name: Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) Condition: Leukemia Date: 2010-08-27 Interventions: Drug: Alemtuzumab 10 mg by vein over 2 hours on Days 1 to 10 of a 28 day cycle. |
Completed |
Study Name: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-04-29 Interventions: Drug: sunitinib malate Given P |
Terminated |
Study Name: Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia Condition: Large Granular Lymphocytic Leukemia LGL L Date: 2006-08-10 Interventions: Drug: Cyclosporine An oral pre |
Terminated |
Study Name: Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia Condition: Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Date: 2006-08-03 Interventions: Drug: tipifarnib Given orally |